An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals
Mrowietz, U., Kragballe, K., Reich, K., Griffiths, C.E.M., Gu, Y., Wang, Y., Rozzo, S.J.Volume:
168
Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/j.1365-2133.2012.11214.x
Date:
February, 2013
File:
PDF, 220 KB
english, 2013